Clinical Trial Update: Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ZD6126 in combination with oxaliplatin, 5-fluorouracil and leucovorin in metastatic colorectal cancer; the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• ZD6126 (ZD6126)

Snippet

Sponsor: AstraZeneca | Conditions: Colorectal Neoplasms, Metastases, Neoplasm | Phase 2 | Status: TERMINATED